Barclays analyst Hassan Al-Wakeel downgraded Sonova (SONVY) to Underweight from Equal Weight with a price target of CHF 225, down from CHF 275. The firm believes the stock’s valuation remains elevated relative to peers despite downside risks to the fiscal year guidance.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: